-
15479-1A primary amide analog of (+)-JQ1 which has shown superior bioavailability with oral or i.p.
-
15479-10A primary amide analog of (+)-JQ1 which has shown superior bioavailability with oral or i.p.
-
15479-25A primary amide analog of (+)-JQ1 which has shown superior bioavailability with oral or i.p.
-
15479-5A primary amide analog of (+)-JQ1 which has shown superior bioavailability with oral or i.p.
-
19125-1A selective EZH2 inhibitor (IC<sub>50</sub>s = 0.5 and 2.
-
19125-10A selective EZH2 inhibitor (IC<sub>50</sub>s = 0.5 and 2.
-
19125-5A selective EZH2 inhibitor (IC<sub>50</sub>s = 0.5 and 2.
-
19125-500A selective EZH2 inhibitor (IC<sub>50</sub>s = 0.5 and 2.
-
16981-10A lipoic acid analog that inhibits &alpha-ketoglutarate dehydrogenase, particularly in tumor cells induces a strong mitochondrial burst of reactive oxygen species at 60-240 µM, resulting in cell death demonstrates both in vitro and in vivo
-
16981-25A lipoic acid analog that inhibits &alpha-ketoglutarate dehydrogenase, particularly in tumor cells induces a strong mitochondrial burst of reactive oxygen species at 60-240 µM, resulting in cell death demonstrates both in vitro and in vivo
-
16981-5A lipoic acid analog that inhibits &alpha-ketoglutarate dehydrogenase, particularly in tumor cells induces a strong mitochondrial burst of reactive oxygen species at 60-240 µM, resulting in cell death demonstrates both in vitro and in vivo
-
16981-50A lipoic acid analog that inhibits &alpha-ketoglutarate dehydrogenase, particularly in tumor cells induces a strong mitochondrial burst of reactive oxygen species at 60-240 µM, resulting in cell death demonstrates both in vitro and in vivo